Potential Applications
Today, more than 300 clinical trials are ongoing worldwide to uncover the potential of MSCs. Thus far, encouraging results have been published; stem cell treatments have been proven safe and capable of repairing damage caused by stroke and heart disease. MSCs have also been used in combination with HSCs as a dual therapy to promote faster engraftment of HSCs and to reduce immune system complications.
Disorders investigated in MSC Clinical Trials |
Disorders investigated in EpSC Clinical Trials |
- Tissue repair
- Stroke
- Heart failure
- Alzheimer’s disease
- Parkinson’s disease
- Spinal cord injury
- Orthopaedic indications (bone, cartilage, tendon repair)
- Liver failure
- Immune modulation or reconstitution
- HIV
- Type 1 diabetes
- Graft versus host disease (GvHD)
- HSCs engraftment support
- Shorten time of engraftment
- Reduce immune system complications
|
- Soft tissue repair
- Skin wounds
- Ocular surface disorders
- Persistent epithelial defect
- Replacement of insulin-producing cells for diabetic patients
- Haemophilia
|